Association Between Time to Initiation of Adjuvant Chemotherapy and Survival in Colorectal Cancer A Systematic Review and Meta-analysis

被引:500
作者
Biagi, James J. [1 ]
Raphael, Michael J. [2 ]
Mackillop, William J. [1 ,2 ,3 ]
Kong, Weidong [2 ]
King, Will D. [3 ]
Booth, Christopher M. [1 ,2 ]
机构
[1] Queens Univ, Dept Oncol, Kingston, ON K7L 5P9, Canada
[2] Queens Univ, Div Canc Care & Epidemiol, Canc Res Inst, Kingston, ON K7L 5P9, Canada
[3] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON K7L 5P9, Canada
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2011年 / 305卷 / 22期
基金
加拿大健康研究院;
关键词
III COLON-CANCER; STAGE-II; PUBLICATION BIAS; RECTAL-CANCER; FLUOROURACIL; LEUCOVORIN; THERAPY; ANGIOGENESIS; RADIOTHERAPY; OXALIPLATIN;
D O I
10.1001/jama.2011.749
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Adjuvant chemotherapy (AC) improves survival among patients with resected colorectal cancer. However, the optimal timing from surgery to initiation of AC is unknown. Objective To determine the relationship between time to AC and survival outcomes via a systematic review and meta-analysis. Data Sources MEDLINE (1975 through January 2011), EMBASE, the Cochrane Database of Systematic Reviews, and the Cochrane Central Register of Controlled Trials were searched to identify studies that described the relationship between time to AC and survival. Study Selection Studies were only included if the relevant prognostic factors were adequately described and either comparative groups were balanced or results adjusted for these prognostic factors. Data Extraction Hazard ratios (HRs) for overall survival and disease-free survival from each study were converted to a regression coefficient (beta) and standard error corresponding to a continuous representation per 4 weeks of time to AC. The adjusted beta from individual studies were combined using a fixed-effects model. Inverse variance (1/SE2) was used to weight individual studies. Publication bias was investigated using the trim and fill approach. Results We identified 10 eligible studies involving 15 410 patients (7 published articles, 3 abstracts). Nine of the studies were cohort or population based and 1 was a secondary analysis from a randomized trial of chemotherapy. Six studies reported time to AC as a binary variable and 4 as 3 or more categories. Meta-analysis demonstrated that a 4-week increase in time to AC was associated with a significant decrease in both overall survival (HR, 1.14; 95% confidence interval [CI], 1.10-1.17) and disease-free survival (HR, 1.14; 95% CI, 1.10-1.18). There was no significant heterogeneity among included studies. Results remained significant after adjustment for potential publication bias and when the analysis was repeated to exclude studies of largest weight. Conclusion In a meta-analysis of the available literature on time to AC, longer time to AC was associated with worse survival among patients with resected colorectal cancer.
引用
收藏
页码:2335 / 2342
页数:8
相关论文
共 46 条
  • [31] Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI [10.3322/caac.20006, 10.3322/caac.21387]
  • [32] Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: Results from NSABP C-07
    Kuebler, J. Philip
    Wieand, H. Samuel
    O'Connell, Michael J.
    Smith, Roy E.
    Colangelo, Linda H.
    Yothers, Greg
    Petrelli, Nicholas J.
    Findlay, Michael P.
    Seay, Thomas E.
    Atkins, James N.
    Zapas, John L.
    Goodwin, J. Wendall
    Fehrenbacher, Louis
    Ramanathan, Ramesh K.
    Conley, Barbara A.
    Flynn, Patrick J.
    Soori, Gamini
    Colman, Lauren K.
    Levine, Edward A.
    Lanier, Keith S.
    Wolmark, Norman
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (16) : 2198 - 2204
  • [33] Laparoscopy-assisted colectomy versus open colectomy for treatment of non-metastatic colon cancer:: a randomised trial
    Lacy, AM
    García-Valdecasas, JC
    Delgado, S
    Castells, A
    Taurá, P
    Piqué, JM
    Visa, J
    [J]. LANCET, 2002, 359 (9325) : 2224 - 2229
  • [34] USERS GUIDES TO THE MEDICAL LITERATURE .4. HOW TO USE AN ARTICLE ABOUT HARM
    LEVINE, M
    WALTER, S
    LEE, H
    HAINES, T
    HOLBROOK, A
    MOYER, V
    GUYATT, G
    BASS, E
    BROWMAN, G
    COOK, D
    FARKOUH, M
    GERSTEIN, H
    HAYWARD, R
    HAYNES, B
    JAESCHKE, R
    JUNIPER, E
    LAUPACIS, A
    NAYLOR, D
    NISHIKAWA, J
    OXMAN, A
    PATEL, A
    PHILBRICK, J
    RICHARDSON, S
    SAUVE, S
    SACKETT, D
    SINCLAIR, J
    STROM, B
    TROUT, KS
    TUNIS, S
    WILLIAMS, J
    WILSON, M
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (20): : 1615 - 1619
  • [35] Association Between Receipt and Timing of Adjuvant Chemotherapy and Survival for Patients With Stage III Colon Cancer in Alberta, Canada
    Lima, Isac S. F.
    Yasui, Yutaka
    Scarfe, Andrew
    Winget, Marcy
    [J]. CANCER, 2011, 117 (16) : 3833 - 3840
  • [36] Killing time: The consequences of delays in radiotherapy
    Mackillop, William J.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2007, 84 (01) : 1 - 4
  • [37] MCCULLOCH P, 1994, LANCET, V344, P402
  • [38] National Institutes of Health, 1990, ADJ THER PAT COL REC, V8, P1
  • [39] Is minimal access surgery for cancer associated with immunologic benefits?
    Ng, CSH
    Whelan, RL
    Lacy, AM
    Yim, APC
    [J]. WORLD JOURNAL OF SURGERY, 2005, 29 (08) : 975 - 981
  • [40] A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
    O'Brien, Catherine A.
    Pollett, Aaron
    Gallinger, Steven
    Dick, John E.
    [J]. NATURE, 2007, 445 (7123) : 106 - 110